# Methoclopramide for Gastroesophageal Reflux in Premature Infants

> **NCT02907632** · PHASE4 · COMPLETED · sponsor: **Nathalie Charpak** · enrollment: 490 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Metoclopramide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02907632
- **Lead sponsor:** Nathalie Charpak
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-26
- **Primary completion:** 2019-01-31
- **Final completion:** 2019-01-31
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2020-09-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907632, "Methoclopramide for Gastroesophageal Reflux in Premature Infants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02907632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*